Manufacturing, Gene Therapies

Exothera Partners with Remedium to Scale-Up Manufacturing of Gene Therapy Drug Candidate

March 30, 2023

CDMO Exothera and biotech company Remedium are joining forces to scale up the manufacturing process for Remedium’s lead gene therapy candidate for treating osteoarthritis.

TrakCel and Lonza Reach Integration Milestone to Combine Cell and Gene Therapy Manufacturing, Orchestration Solutions

March 22, 2023

The combined solutions are currently available on the market.

Sartorius and Teknova Team Up for Gene Therapy Process Development

March 21, 2023

Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.

Catalent Expands UpTempo AAV Platform

March 09, 2023

Catalent is expanding its UpTempo AAV platform to accelerate the development of gene therapies.

Tactics and Strategies for Designing an Ideal Lentiviral Vector Platform

March 01, 2023

There is growing pressure for robust and economically scalable viral-vector manufacturing technologies.

AbbVie and Capsida Strike $674 Million Gene Therapy Development Deal

February 24, 2023

AbbVie and Capsida have expanded their existing collaboration to advance three new gene therapy programs.

Robust Development Fuels Drive to Finish Line

February 02, 2023

A slew of late-stage clinical trials is expected to push new regenerative medicines onto the market in the next few years.

Optimizing Vectors to Standardize Success

February 02, 2023

Improvement in viral vector yield has become integral to new cell and gene therapy product development.

Emmes Launches Cell and Gene Therapy Center

December 14, 2022

Emmes’ new facility is designed to support clients conducting cell and gene therapy research worldwide.

CSafe and BioLife Solutions Partnership Will Expand Supply Chain for Cell and Gene Therapies

October 28, 2022

The newly formed partnership between CSafe and BioLife will expand cold chain supply chain solutions for the cell and gene therapy market.